Anthrax - Key Documents

Quick References News
Education & Training Official Remarks
& Reports
Internet Resources Key Documents
Government    Academic    Professional
Products  What's New

Government Documents

Centers for Disease Control and Prevention (CDC)
Defense Threat Reduction Agency (DTRA)
Department of Defense Documents (DOD)
Food and Drug Administration (FDA)
United States National Library of Medicine (NLM)
World Health Organization (WHO)

 

  Centers for Disease Control and Prevention (CDC)

Bioterrorism Readiness Plan: A Template for Healthcare Facilities
The Association for Professionals in Infection Control and Epidemiology (APIC) recognizes the importance of awareness and preparation for bioterrorism on the part of healthcare facilities. In cooperation with the Centers for Disease Control and Prevention (CDC), template to facilitate preparation of bioterrorism readiness plans for individual institutions.

Notice to Readers: Occupational Health Guidelines for Remediation Workers at Bacillus anthracis-Contaminated Sites --- United States, 2001--2002

Official CDC Health Advisory: Use of Ciprofloxacin or Doxycycline for post-exposure prophylaxis for prevention of inhalation anthrax, October 31, 2001 (HAB #49)

CDC Interim recommendations for protecting workers from exposure to Bacillus anthracis in work sites where mail is handled or processed, October 31, 2001 (HAN #51)

Update: Investigation of Anthrax associated with intentional exposure and interim public health guidelines, October 2001

Updated information about how to recognize and handle a suspicious package or envelope, October 2001 (HAN #50)

Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial Therapy, October 2001

Procedures for collecting surface environmental samples for culturing Bacillus anthracis

Protecting investigators performing environmental sampling for Bacillus anthracis: Personal protective equipment

Interim recommendations for the selection and use of protective clothing and respirators against biological agents

Interim Recommendations for the Selection and Use of Protective Clothing and Respirators Against Biological Agents

Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax

 

  Defense Threat Reduction Agency (DTRA)

Lessons from the Anthrax Attacks: Implications for U.S. Bioterrorism Preparedness
April 2002, DTRA

 

  Department of Defense Documents (DOD)

Anthrax Updates - AFIS Study Could Reduce Anthrax Shots, Decrease Side Effects
November 1, 2002, Karen Fleming-Michael

 

  Food and Drug Administration (FDA)

Anthrax
June 24, 2002

Cipro for Inhalation Anthrax
November 14, 2001

Label Revisions for two Anthrax Drugs
October 30, 2001

Doxycycline Use by Pregnant and Lactating Women
October 30, 2001

Approval of Cipro for Anthrax
August 31, 2000

 

 
  United States National Library of Medicine (NLM)
Anthrax, Latest News
November 21, 2002
 
  World Health Organization (WHO)

Guidelines for the Surveillance and Control of Anthrax in Humans and Animals

International Travel and Health

 
 

 

 

 

3545 Lafayette • Suite 300 • St. Louis, Missouri 63104 • USA • (314) 977-8257 • Copyright © Saint Louis University

Upcoming Events     Products     Center Research     In Case of Emergency     Contact Us     About Us